ZEOXOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30

Zeo ScientifiX, Inc.

Financials through Q2 FY2026, quarter ended Apr 30, 2026Last filing: 10-Q on Jun 15, 2026

$0.91+0.00 (+0.15%)

Close on Oct 19, 2026

Community

Notes and questions about Zeo ScientifiX from other investors

Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.

Parsed from the XBRL in Zeo ScientifiX's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-200 reverse split on Jan 29, 2024
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ZEOX.

Gross margin81.5% · median 37.0%

Operating margin-59.1% · median -205.2%

Net margin-55.6% · median -223.5%

Advertisement
300 × 250